Literature DB >> 25440120

Upcoming rules and benchmarks concerning the monitoring of and the payment for surgical infections.

Nitin Sajankila1, John J Como1, Jeffrey A Claridge2.   

Abstract

There has been a good deal of dialogue about pay for performance and linking outcomes with reimbursement, especially given the recent national health care legislation. Many such concerns are caused by upcoming changes that have been outlined in the Affordable Care Act. This article discusses these upcoming changes and reviews some of the literature that supports them, specifically those related to surgical infections. Likewise, the lack of support for some of these changes in the academic literature is discussed. Finally, some of the proposed key benchmarks and the methodologies behind the design of those benchmarks are discussed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Keywords:  Pay for performance; SCIP; Surgery; Surgical infections; Value-based purchasing

Mesh:

Year:  2014        PMID: 25440120     DOI: 10.1016/j.suc.2014.08.012

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

1.  Whipple-specific complications result in prolonged length of stay not accounted for in ACS-NSQIP Surgical Risk Calculator.

Authors:  Brian M Cusworth; Bradley A Krasnick; Timothy M Nywening; Cheryl A Woolsey; Ryan C Fields; Maria M Doyle; Jingxia Liu; William G Hawkins
Journal:  HPB (Oxford)       Date:  2016-12-08       Impact factor: 3.647

2.  Distinction of Risk Factors for Superficial vs Organ-Space Surgical Site Infections After Pancreatic Surgery.

Authors:  Irmina A Elliott; Carmen Chan; Tara A Russell; Amanda M Dann; Jennifer L Williams; Lauren Damato; Hallie Chung; Mark D Girgis; O Joe Hines; Howard A Reber; Timothy R Donahue
Journal:  JAMA Surg       Date:  2017-11-01       Impact factor: 14.766

3.  Unbundling Bundles: Evaluating the Association of Individual Colorectal Surgical Site Infection Reduction Bundle Elements on Infection Rates in a Statewide Collaborative.

Authors:  Cary Jo R Schlick; Reiping Huang; Brian C Brajcich; Amy L Halverson; Anthony D Yang; Lindsey Kreutzer; Karl Y Bilimoria; Michael F McGee
Journal:  Dis Colon Rectum       Date:  2022-07-05       Impact factor: 4.412

4.  Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus.

Authors:  Tae Jung Oh; Chang Ho Ahn; Bo-Rahm Kim; Kyoung Min Kim; Jae Hoon Moon; Soo Lim; Kyong Soo Park; Cheong Lim; HakChul Jang; Sung Hee Choi
Journal:  Cardiovasc Diabetol       Date:  2017-07-20       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.